Diagnosis and Management of Precocious Puberty in Atypical Presentations ofMcCune-Albright Syndrome: A Case Series Review

Journal of Pediatric and Adolescent Gynecology

Volumn 25, Issue 1, 2012, Pages e9-

  Bercaw Pratt, Jennifer L ^a   Moorjani, Tracy Patel ^a   Santos, Xiomara M ^a   Karaviti, Lefkothea ^a   Dietrich, Jennifer E ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANASTROZOLE; ESTRADIOL; GONADORELIN AGONIST; GONADOTROPIN; LETROZOLE;

ALBRIGHT SYNDROME; ARTICLE; BACTERIUM CULTURE; BONE AGE; CAFE AU LAIT SPOT; CASE REPORT; CHILD; DISEASE PREDISPOSITION; FEMALE; FIBROUS DYSPLASIA; FOLLOW UP; GARDNERELLA VAGINALIS; HISPANIC; HORMONAL REGULATION; HUMAN; LABORATORY TEST; PHYSICAL EXAMINATION; PRECOCIOUS PUBERTY; PREPUBERTY; PRESCHOOL CHILD; PRIORITY JOURNAL; SKIN EXAMINATION; STREPTOCOCCUS AGALACTIAE; TREATMENT DURATION; VAGINA BLEEDING; VAGINA DISCHARGE;

EID: 84855318104     PISSN: 10833188     EISSN: 18734332     Source Type: Journal    
DOI: 10.1016/j.jpag.2011.09.005     Document Type: Article

References (14)

1. Wagoner H., Steinmetz R., Bethin K., et al. GNAS mutation detection is related to disease severity in girls with McCune-Albright syndrome and precocious puberty. Pediatr Endocrinol Rev 2007, 4:395.
2. Marshall W., Tanner J. Variations in the pattern of pubertal changes in girls. Arch Dis Child 1969, 44:291.
3. Kaplowitz P., Oberfield S. Reexamination of the age limit for defining when puberty is precocious in girls in the United States: implications for evaluation and treatment. Drug and Therapeutics and Executive Committees of the Lawson Wilkins Pediatric Endocrine Society. Pediatrics 1999, 104:936.
4. Rosenfield R., Bachrach L., Chernausek S., et al. Current age of onset of puberty. Pediatrics 2000, 106:622.
5. Weinstein L., Shenker A., Gejman P., et al. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N Engl J Med 1991, 325:1688.
6. Lumbroso S., Paris F., Sultan C. European Collaborative Study: Activating Gsalpha mutations: analysis of 113 patients with signs of McCune-Albright syndrome-a European Collaborative Study. J Clin Endocrinol Metab 2004, 89:2107.
7. Gesmundo R., Guaná R., Valfré L., et al. Laparoscopic management of ovarian cysts in peripheral puberty of McCune-Albright syndrome. J Pediatr Endocrinol Metab 2006, 19(Suppl 2):571.
8. Eugster E., Rubin S., Reiter E., et al. Tamoxifen treatment for precocious puberty in McCune-Albright syndrome: a multicenter trial. J Pediatr 2003, 143:60. McCune-Albright Study Group.
9. Feuillan P., Jones J., Cutler G. Long-term testolactone therapy for precocious puberty in girls with the McCune-Albright syndrome. J Clin Endocrinol Metab 1993, 77:647.
10. Mieszczak J., Lowe E., Plourde P., et al. The aromatase inhibitor anastrazole is ineffective in the treatment of precocious puberty in girls with McCune-Albright syndrome. J Clin Endocrinol Metab 2008, 93:2751.
11. Nunez S., Calis K., Cutler G., et al. Lack of efficacy of fadrazole in treating precocious puberty in girls with the McCune-Albright syndrome. J Clin Endocrinol Metab 2003, 88:5730.
12. Feuillan P., Calis K., Hill S., et al. Letrozole treatment of precocious puberty in girls with the McCune-Albright syndrome: a pilot study. J Clin Endocrinol Metab 2007, 92:2100.
13. Feuillan P., Jones J., Oerter K., et al. Luteinizing hormone-releasing hormone (LHRH)-independent precocious puberty unresponsive to LHRH agonist therapy in two girls lacking features of the McCune-Albright syndrome. J Clin Endocrinol Metab 1991, 73:1370.
14. Herter L.D., Golendziner E., Flores J.A., et al. Ovarian and uterine sonography in healthy girls between 1 and 13 years old: correlation of findings with age and pubertal status. AJR Am J Roentgenol 2002, 178:1531.